,33 It has been suggested that the addition of cytotoxic agents abolishes the capacity of PD-L1 to reflect the level of engagement of PD-L1 inhibitors with their corresponding targets on the surface of cancer or immune cells.34 The gene discussed is CD274; the disease is cancer.